Sponsored by Digital Look Events

Market Cap

£3.14m

Change Today

0.000p

Share Price

6.75p

Latest ShareCast News

ValiRx granted Aussie patent for GeneICE

Date: Tuesday 29 Jan 2008

ValiRx headed higher Tuesday after the cancer treatment company said its proprietary gene-silencing technology, GeneICE, has received patent approval in Australia.

ValiRx Regulatory News

Holding(s) in Company 15-May-2008 12:37 RNS
Statement re Placing of Shares 12-May-2008 16:42 PR Newswire
Issue of Equity 08-May-2008 08:05 RNS
Holding(s) in Company 07-May-2008 14:20 RNS
Result of EGM 02-May-2008 11:35 RNS

ValiRx News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

ValiRx Market Data

Currency UK Pounds
Share Price 6.75p  
Change Today 0.000p
52 Week High 29.25p
52 Week Low 6.50p
Volume 0
Shares Issued 46.50m
Market Cap £3.14m
Beta 0.47
RiskGrade 313

ValiRx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
8.86% above the market average8.86% above the market average8.86% above the market average8.86% above the market average8.86% above the market average
34.12% above the sector average34.12% above the sector average34.12% above the sector average34.12% above the sector average34.12% above the sector average
Price Trend
74.15% below the market average74.15% below the market average74.15% below the market average74.15% below the market average74.15% below the market average
47.25% below the sector average47.25% below the sector average47.25% below the sector average47.25% below the sector average47.25% below the sector average
Income Not Available
Growth Not Available

ValiRx Dividends

No dividends found

Trades for --2008

Time Volume / Share Price
0 @ 0.000p